APO Research
Talk to an analyst

APO RESEARCH · REPORT

Wilms' Tumor Treatment

Compare research editions
View pricing & licenses

Selected research

Industry Research

Wilms' Tumor Treatment Industry Research Report 2026

19 December 2025100 pages

Choose your research edition.

Industry ResearchWilms' Tumor Treatment Industry Research Report 2026100 pages · $2,950 USDIndustry Growth & TrendsGlobal Wilms' Tumor Treatment Industry Growth and Trends Forecast to 203260 pages · $3,450 USDMarket StructureGlobal Wilms' Tumor Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Wilms' Tumor Treatment Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Wilms' Tumor Treatment Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Wilms' Tumor Treatment market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the Wilms' Tumor Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Wilms' Tumor Treatment market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Wilms' Tumor Treatment market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Wilms' Tumor Treatment include Selvita SA, Recombio SL, NanoSmart Pharmaceuticals Inc and Exelixis Inc, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global Wilms' Tumor Treatment market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Wilms' Tumor Treatment.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Wilms' Tumor Treatment Market by Company

Selvita SA

Recombio SL

NanoSmart Pharmaceuticals Inc

Exelixis Inc

Wilms' Tumor Treatment Segment by Type

Racotumomab

Cabozantinib s

SEL-12034

Others

Wilms' Tumor Treatment Segment by Application

Hospital

Clinic

Others

Wilms' Tumor Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Wilms' Tumor Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Wilms' Tumor Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Wilms' Tumor Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Wilms' Tumor Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Wilms' Tumor Treatment Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Wilms' Tumor Treatment Revenue Market Share by Type (2021-2026) Table 7. Global Wilms' Tumor Treatment Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Wilms' Tumor Treatment Revenue Market Share by Type (2027-2032) Table 9. Global Wilms' Tumor Treatment Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Wilms' Tumor Treatment Revenue Market Share by Application (2021-2026) Table 11. Global Wilms' Tumor Treatment Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Wilms' Tumor Treatment Revenue Market Share by Application (2027-2032) Table 13. Global Wilms' Tumor Treatment Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Wilms' Tumor Treatment Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Wilms' Tumor Treatment Market Share by Region (2021-2026) Table 16. Global Wilms' Tumor Treatment Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Wilms' Tumor Treatment Market Share by Region (2027-2032) Table 18. Wilms' Tumor Treatment Industry Trends Table 19. Wilms' Tumor Treatment Industry Drivers Table 20. Wilms' Tumor Treatment Industry Opportunities and Challenges Table 21. Wilms' Tumor Treatment Market Restraints Table 22. Global Top Wilms' Tumor Treatment Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Wilms' Tumor Treatment Revenue Market Share by Players (2021-2026) Table 24. Global Wilms' Tumor Treatment Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Wilms' Tumor Treatment, Headquarters and Area Served Table 26. Global Wilms' Tumor Treatment Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Wilms' Tumor Treatment by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Wilms' Tumor Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Wilms' Tumor Treatment Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Wilms' Tumor Treatment Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Wilms' Tumor Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Wilms' Tumor Treatment Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Wilms' Tumor Treatment Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Wilms' Tumor Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Wilms' Tumor Treatment Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Wilms' Tumor Treatment Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Wilms' Tumor Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Wilms' Tumor Treatment Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Wilms' Tumor Treatment Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Wilms' Tumor Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Wilms' Tumor Treatment Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Wilms' Tumor Treatment Market Size by Country (2027-2032) & (US$ Million) Table 45. Selvita SA Company Information Table 46. Selvita SA Business Overview Table 47. Selvita SA Revenue in Wilms' Tumor Treatment Business (2021-2026) & (US$ Million) Table 48. Selvita SA Wilms' Tumor Treatment Product Portfolio Table 49. Selvita SA Recent Developments Table 50. Recombio SL Company Information Table 51. Recombio SL Business Overview Table 52. Recombio SL Revenue in Wilms' Tumor Treatment Business (2021-2026) & (US$ Million) Table 53. Recombio SL Wilms' Tumor Treatment Product Portfolio Table 54. Recombio SL Recent Developments Table 55. NanoSmart Pharmaceuticals Inc Company Information Table 56. NanoSmart Pharmaceuticals Inc Business Overview Table 57. NanoSmart Pharmaceuticals Inc Revenue in Wilms' Tumor Treatment Business (2021-2026) & (US$ Million) Table 58. NanoSmart Pharmaceuticals Inc Wilms' Tumor Treatment Product Portfolio Table 59. NanoSmart Pharmaceuticals Inc Recent Developments Table 60. Exelixis Inc Company Information Table 61. Exelixis Inc Business Overview Table 62. Exelixis Inc Revenue in Wilms' Tumor Treatment Business (2021-2026) & (US$ Million) Table 63. Exelixis Inc Wilms' Tumor Treatment Product Portfolio Table 64. Exelixis Inc Recent Developments Table 65. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Wilms' Tumor Treatment Product Image Figure 5. Global Wilms' Tumor Treatment Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Wilms' Tumor Treatment Market Share by Type: 2025 VS 2032 Figure 7. Racotumomab Product Figure 8. Cabozantinib s Product Figure 9. SEL-12034 Product Figure 10. Others Product Figure 11. Global Wilms' Tumor Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Wilms' Tumor Treatment Market Share by Application: 2025 VS 2032 Figure 13. Hospital Product Figure 14. Clinic Product Figure 15. Others Product Figure 16. Global Wilms' Tumor Treatment Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 17. Global Wilms' Tumor Treatment Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Wilms' Tumor Treatment Market Share by Region: 2025 VS 2032 Figure 19. Global Wilms' Tumor Treatment Market Share by Players in 2025 Figure 20. Global Wilms' Tumor Treatment Manufacturers Established Date Figure 21. Global Top 5 and 10 Wilms' Tumor Treatment Players Market Share by Revenue in 2025 Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. North America Wilms' Tumor Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Wilms' Tumor Treatment Market Share by Country (2021-2032) Figure 25. United States Wilms' Tumor Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 26. Canada Wilms' Tumor Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Mexico Wilms' Tumor Treatment Market Share by Country (2021-2032) Figure 28. Europe Wilms' Tumor Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Wilms' Tumor Treatment Market Share by Country (2021-2032) Figure 30. Germany Wilms' Tumor Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. France Wilms' Tumor Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. U.K. Wilms' Tumor Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Italy Wilms' Tumor Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Spain Wilms' Tumor Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Russia Wilms' Tumor Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Netherlands Wilms' Tumor Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Nordic Countries Wilms' Tumor Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Wilms' Tumor Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Wilms' Tumor Treatment Market Share by Country (2021-2032) Figure 40. China Wilms' Tumor Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. Japan Wilms' Tumor Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. South Korea Wilms' Tumor Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. India Wilms' Tumor Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 44. India Wilms' Tumor Treatment Market Share by Country (2021-2032) Figure 45. Australia Wilms' Tumor Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. China Taiwan Wilms' Tumor Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. Southeast Asia Wilms' Tumor Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 48. South America Wilms' Tumor Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 49. South America Wilms' Tumor Treatment Market Share by Country (2021-2032) Figure 50. Brazil Wilms' Tumor Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. Argentina Wilms' Tumor Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Chile Wilms' Tumor Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. Colombia Wilms' Tumor Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 54. Peru Wilms' Tumor Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 55. Selvita SA Revenue Growth Rate in Wilms' Tumor Treatment Business (2021-2026) Figure 56. Recombio SL Revenue Growth Rate in Wilms' Tumor Treatment Business (2021-2026) Figure 57. NanoSmart Pharmaceuticals Inc Revenue Growth Rate in Wilms' Tumor Treatment Business (2021-2026) Figure 58. Exelixis Inc Revenue Growth Rate in Wilms' Tumor Treatment Business (2021-2026)

Scope & coverage.

Types
  • Racotumomab
  • Cabozantinib s
  • SEL-12034
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Selvita SA
  • Recombio SL
  • NanoSmart Pharmaceuticals Inc
  • Exelixis Inc

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Wilms' Tumor Treatment by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 Racotumomab
  5. 2.2.3 Cabozantinib s
  6. 2.2.4 SEL-12034
  7. 2.2.5 Others
  8. 2.3 Wilms' Tumor Treatment by Application
  9. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  10. 2.3.2 Hospital
  11. 2.3.3 Clinic
  12. 2.3.4 Others
  13. 2.4 Assumptions and Limitations
3 Wilms' Tumor Treatment Breakdown Data by Type
  1. 3.1 Global Wilms' Tumor Treatment Historic Market Size by Type (2021-2026)
  2. 3.2 Global Wilms' Tumor Treatment Forecasted Market Size by Type (2027-2032)
4 Wilms' Tumor Treatment Breakdown Data by Application
  1. 4.1 Global Wilms' Tumor Treatment Historic Market Size by Application (2021-2026)
  2. 4.2 Global Wilms' Tumor Treatment Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global Wilms' Tumor Treatment Market Perspective (2021-2032)
  2. 5.2 Global Wilms' Tumor Treatment Growth Trends by Region
  3. 5.2.1 Global Wilms' Tumor Treatment Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 Wilms' Tumor Treatment Historic Market Size by Region (2021-2026)
  5. 5.2.3 Wilms' Tumor Treatment Forecasted Market Size by Region (2027-2032)
  6. 5.3 Wilms' Tumor Treatment Market Dynamics
  7. 5.3.1 Wilms' Tumor Treatment Industry Trends
  8. 5.3.2 Wilms' Tumor Treatment Market Drivers
  9. 5.3.3 Wilms' Tumor Treatment Market Challenges
  10. 5.3.4 Wilms' Tumor Treatment Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top Wilms' Tumor Treatment Players by Revenue
  2. 6.1.1 Global Top Wilms' Tumor Treatment Players by Revenue (2021-2026)
  3. 6.1.2 Global Wilms' Tumor Treatment Revenue Market Share by Players (2021-2026)
  4. 6.2 Global Wilms' Tumor Treatment Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of Wilms' Tumor Treatment Head Office and Area Served
  6. 6.4 Global Wilms' Tumor Treatment Players, Product Type & Application
  7. 6.5 Global Wilms' Tumor Treatment Manufacturers Established Date
  8. 6.6 Global Wilms' Tumor Treatment Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America Wilms' Tumor Treatment Market Size (2021-2032)
  2. 7.2 North America Wilms' Tumor Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America Wilms' Tumor Treatment Market Size by Country (2021-2026)
  4. 7.4 North America Wilms' Tumor Treatment Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe Wilms' Tumor Treatment Market Size (2021-2032)
  2. 8.2 Europe Wilms' Tumor Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe Wilms' Tumor Treatment Market Size by Country (2021-2026)
  4. 8.4 Europe Wilms' Tumor Treatment Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific Wilms' Tumor Treatment Market Size (2021-2032)
  2. 9.2 Asia-Pacific Wilms' Tumor Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific Wilms' Tumor Treatment Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific Wilms' Tumor Treatment Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America Wilms' Tumor Treatment Market Size (2021-2032)
  2. 10.2 South America Wilms' Tumor Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America Wilms' Tumor Treatment Market Size by Country (2021-2026)
  4. 10.4 South America Wilms' Tumor Treatment Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa Wilms' Tumor Treatment Market Size (2021-2032)
  2. 11.2 Middle East & Africa Wilms' Tumor Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa Wilms' Tumor Treatment Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa Wilms' Tumor Treatment Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 Selvita SA
  2. 12.1.1 Selvita SA Company Information
  3. 12.1.2 Selvita SA Business Overview
  4. 12.1.3 Selvita SA Revenue in Wilms' Tumor Treatment Business (2021-2026)
  5. 12.1.4 Selvita SA Wilms' Tumor Treatment Product Portfolio
  6. 12.1.5 Selvita SA Recent Developments
  7. 12.2 Recombio SL
  8. 12.2.1 Recombio SL Company Information
  9. 12.2.2 Recombio SL Business Overview
  10. 12.2.3 Recombio SL Revenue in Wilms' Tumor Treatment Business (2021-2026)
  11. 12.2.4 Recombio SL Wilms' Tumor Treatment Product Portfolio
  12. 12.2.5 Recombio SL Recent Developments
  13. 12.3 NanoSmart Pharmaceuticals Inc
  14. 12.3.1 NanoSmart Pharmaceuticals Inc Company Information
  15. 12.3.2 NanoSmart Pharmaceuticals Inc Business Overview
  16. 12.3.3 NanoSmart Pharmaceuticals Inc Revenue in Wilms' Tumor Treatment Business (2021-2026)
  17. 12.3.4 NanoSmart Pharmaceuticals Inc Wilms' Tumor Treatment Product Portfolio
  18. 12.3.5 NanoSmart Pharmaceuticals Inc Recent Developments
  19. 12.4 Exelixis Inc
  20. 12.4.1 Exelixis Inc Company Information
  21. 12.4.2 Exelixis Inc Business Overview
  22. 12.4.3 Exelixis Inc Revenue in Wilms' Tumor Treatment Business (2021-2026)
  23. 12.4.4 Exelixis Inc Wilms' Tumor Treatment Product Portfolio
  24. 12.4.5 Exelixis Inc Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst